Table of Contents
At the recently concluded Asia Pharma Expo 2025 in Bangladesh, Shandong Tianming Pharmaceutical Group’s booth, as China’s leading manufacturer of pharmaceutical intermediates and APIs, became the center of attention. During the exhibition, representatives of pharmaceutical companies and industry experts from more than 30 countries were in constant flow, and the number of on-site inquiries exceeded 500, which demonstrated the importance of China’s smart manufacturing in the global pharmaceutical supply chain.
As the world’s second largest exporter of generic drugs, Bangladesh’s demand for high-quality intermediates and APIs continues to rise. This year’s exhibition attracted more than 300 international exhibitors and over 10,000 pharmaceutical companies, becoming a key platform to connect the South Asia, Southeast Asia and Middle East markets.
Shandong Tianming’s booth attracted many international buyers with its distinctive brand image and interactive technology display. Among them, TMC’s core product lines were highly sought after, not only becoming the focus of attention of the attendees and triggering customers’ intention to purchase in bulk, but also the expert team, with rich industry experience and professional knowledge, provided customers with detailed answers and professional advice, which won the customers’ unanimous praise.
During the exhibition, Shandong Tianming team won wide recognition and trust with its excellent R&D innovation, solid compliance guarantee and high cooperation flexibility.
The company not only owns more than 200 patented technologies and has successfully overcome industry challenges such as chiral synthesis and genotoxic impurity control, but also can provide one-stop services from laboratory R&D to tonnage production, which demonstrates its strong technical strength. In terms of logistics, we have established a global logistics tracking system, which realizes temperature control and traceability throughout the transportation of APIs, providing customers with peace of mind.
The exhibition not only provided a platform for us to show our products and technology, but also built a bridge for us to communicate with domestic and foreign customers. Through in-depth exchanges with customers, we better understand the market demand and trend, which provides valuable reference for future product development and market expansion.
Although the exhibition has come to an end, the door of cooperation is always open! TMC will continue to focus on the fields of oncology, diabetes, anti-infective and anti-virus, provide cost-effective intermediates and differentiated APIs for global customers, help enterprises optimize their processes and reduce costs, and help pharmaceutical companies enhance their competitiveness.
In the new era of globalization and localization of pharmaceuticals, Tianming Pharmaceutical will continue to “make innovative drugs, fulfill the dream of health” as the concept, and help our partners to break the waves forward. We look forward to working with you to build a future of “health without borders”!
24-hour professional docking channel has been opened
📧 Email: damon.wang@sdsihuanpharm.com
📱 WhatsApp: +86 133 6541 4469
Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model.
This non-peptide GLP-1 receptor agonist, now in late-stage clinical trials, is redefining possibilities for diabetes and obesity treatment. Let’s unpack what makes it distinctive from both lab bench and manufacturing perspectives.
Comprehensive guide to 2-methylpentanoic acid’s pharmaceutical synthesis roles, industrial applications (lubricants/flavors), production optimization, GMP quality parameters, and global regulatory compliance requirements.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.